
The Week Ahead: COS...


| DNA | Sector Avg. | S&P 500 |
|---|---|---|
| 29.22 | 29.60 | 0.00 |
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 15.52 | 15.80 | 11.82 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 14.40 | 1.02 | 0.26 |
| Net Income | 23.80 | 1.68 | 0.38 |
| EPS | 23.90 | 1.69 | 0.39 |
| EBITDA | 5.92B |
| REVENUE | 13.42B |
| Qtr (03/09) | Qtr (06/09) | FY (12/09) | FY (12/10) | |
|---|---|---|---|---|
| Average Estimate | $0.83 | $0.86 | $3.61 | $4.15 |
| Number of Analysts | 8 | 8 | 10 | 8 |
| High Estimate | $0.88 | $0.91 | $3.81 | $4.33 |
| Low Estimate | $0.79 | $0.82 | $3.46 | $3.87 |
| Prior Year | $0.77 | $0.75 | $3.35 | $3.61 |
| Growth Rate (Year over Year) | 8.28% | 14.67% | 7.61% | 14.98% |